This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/517858-eu-investigating-astrazeneca-covid-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
Version 1 | Version 2 |
---|---|
EU drug regulator investigating 30 reports of blood-clotting linked to AstraZeneca jab as states halt rollout of Covid vaccine | EU drug regulator investigating 30 reports of blood-clotting linked to AstraZeneca jab as states halt rollout of Covid vaccine |
(about 1 month later) | |
The European Medicines Agency (EMA) said on Thursday that it was investigating after two people inoculated from the same batch of AstraZeneca Covid-19 vaccine died from blood clotting and several countries stopped using the jabs. | The European Medicines Agency (EMA) said on Thursday that it was investigating after two people inoculated from the same batch of AstraZeneca Covid-19 vaccine died from blood clotting and several countries stopped using the jabs. |
The inquiry comes after Iceland, Norway, Denmark, Estonia, Lithuania, Luxembourg and Latvia all suspended their rollouts of the AstraZeneca vaccine over fears that they may induce blood clotting – known medically as "thromboembolic events." | The inquiry comes after Iceland, Norway, Denmark, Estonia, Lithuania, Luxembourg and Latvia all suspended their rollouts of the AstraZeneca vaccine over fears that they may induce blood clotting – known medically as "thromboembolic events." |
"There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine," the EMA said in a statement, adding that its own risk assessment committee was investigating the matter. | "There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine," the EMA said in a statement, adding that its own risk assessment committee was investigating the matter. |
As of March 10, there were 30 cases of thromboembolic events reported out of the 5 million people to have received the AstraZeneca jab so far in the European Economic Area, the EMA said in an update on Thursday. | As of March 10, there were 30 cases of thromboembolic events reported out of the 5 million people to have received the AstraZeneca jab so far in the European Economic Area, the EMA said in an update on Thursday. |
The agency also stressed that the vaccine's "benefits continue to outweigh its risks." | The agency also stressed that the vaccine's "benefits continue to outweigh its risks." |
A 60-year-old woman in Denmark died from blood clotting after she received an AstraZeneca jab from batch ABV5300, Danish newspaper Jyllands-Posten reported on Thursday. | A 60-year-old woman in Denmark died from blood clotting after she received an AstraZeneca jab from batch ABV5300, Danish newspaper Jyllands-Posten reported on Thursday. |
On Wednesday, it was reported that a 49-year-old nurse in Austria who was vaccinated from the same batch died from multiple thrombosis 10 days after her jab. | On Wednesday, it was reported that a 49-year-old nurse in Austria who was vaccinated from the same batch died from multiple thrombosis 10 days after her jab. |
Another woman in Austria was hospitalized with a pulmonary embolism after she received one of the batch's 1 million doses that were sent to 17 different EU countries. | Another woman in Austria was hospitalized with a pulmonary embolism after she received one of the batch's 1 million doses that were sent to 17 different EU countries. |
The EMA approved the vaccine developed by AstraZeneca and the UK's Oxford University in January. | The EMA approved the vaccine developed by AstraZeneca and the UK's Oxford University in January. |
Like this story? Share it with a friend! | Like this story? Share it with a friend! |